glp-1 obesity market news today Home Delivery Injectables | Global Market Analysis Report GLP-1s Are Just Getting Started:

The drinks contain a mix of protein and vitamins that will help GLP-1 users reduce weight in a healthy manner.

Coverage Baseline Previously unavailable under Medicare Part D Only 13 states cover them in Medicaid (KFF HMA survey) 19% of large employers cover GLP-1s for obesity, though 43% of employers with 5,000+ employees offer coverage (KFF 2025 survey) Current Expansion ~50% of CVS Caremark clients now provide coverage for weight loss Medicare GLP-1 Bridge program launches coverage for eligible Medicare Part D patients 7/1/26 This aligns with a recent survey from Business Group on Health that found 67% of the surveyed employers now cover GLP-1s for weight loss (though a reduction is expected for 2027)

A better understanding is urgently needed to address the root cause of obesity stigma, which manifests in our misperceptions of obesity.16 This understanding must lead to definitive actions that provide equality to the treatment of obesity within a chronic disease framework, one in which PwO will not be discriminated against and will be equally supported

Weight loss is not a willpower problem

GLP-1 weight loss drugs generally haven't been good news for food companies